세계의 식도암 시장 보고서(2025년)

Esophageal cancer is a form of cancer originating in the cells that line the esophagus, the muscular tube responsible for transporting food and liquids from the neck to the stomach. This malignancy occurs when abnormal cells within the esophagus undergo uncontrolled growth, leading to the development of cancer.

The primary classifications of esophageal cancer include esophageal squamous-cell carcinoma, esophageal adenocarcinoma, and other subtypes. Esophageal squamous-cell carcinoma specifically emerges from the squamous cells lining the esophagus. Treatment options encompass chemotherapy, targeted therapy, and various other approaches, which can be administered orally, parenterally, and through alternative methods. The distribution of treatment products occurs through channels such as hospital pharmacies, online pharmacies, and retail pharmacies, serving institutions such as hospitals, homecare services, specialty centers, and other healthcare facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The esophageal cancer research report is one of a series of new reports from The Business Research Company that provides esophageal cancer market statistics, including the esophageal cancer industry's global market size, regional shares, competitors with a esophageal cancer market share, detailed esophageal cancer market segments, market trends and opportunities, and any further data you may need to thrive in the esophageal cancer industry. This esophageal cancer market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry

The esophageal cancer market size has grown strongly in recent years. It will grow from $1.39 billion in 2024 to $1.51 billion in 2025 at a compound annual growth rate (CAGR) of 9.0%. The growth in the historic period can be attributed to increased number of cancers, improvement in healthcare infrastructure, rise in alcohol consumption, growth in demand for preventive healthcare solutions, increase in prevalence of esophageal adenocarcinoma.

The esophageal cancer market size is expected to see strong growth in the next few years. It will grow to $2.16 billion in 2029 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to rising prevalence of esophageal cancer, increasing public understanding of healthcare, improvements in healthcare infrastructure, chronic consumption of smoking and alcohol, increasing prevalence of esophageal adenocarcinoma. Major trends in the forecast period include technological advancements in treatment options, increased investment in research and development, increasing utilization of precision medicine, development of targeted therapies, increased participation in clinical trials and collaborations between academia, pharmaceutical companies, and healthcare institutions.

The forecast of 9.3% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may pose a significant challenge for the U.S. by restricting access to checkpoint inhibitors and esophageal stents imported from Japan and the Netherlands, potentially compromising cancer treatment outcomes and increasing oncology care burdens. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising incidence of esophageal cancer is expected to drive growth in the esophageal cancer market. Esophageal cancer is a malignancy that affects the esophagus, the tube connecting the throat to the stomach. As more cases are diagnosed, there will be an increased demand for diagnostic procedures such as endoscopy, imaging tests, and biopsies to detect and confirm the disease. For example, the American Cancer Society, a US-based professional organization, reported that in 2023, there were 16,120 new deaths from esophageal cancer, with projections indicating this number will rise to 16,130 in 2024. Therefore, the increase in esophageal cancer cases is anticipated to propel the growth of the esophageal cancer market.

Increased consumption of alcohol is also anticipated to fuel the growth of the esophageal cancer market. Alcohol consumption involves ingesting beverages containing ethanol, which metabolizes into acetaldehyde, a known carcinogen that can damage DNA in esophageal cells. Chronic alcohol consumption can lead to inflammation and irritation in the esophageal lining, creating a conducive environment for cancer development. Notably, in November 2023, data from the Substance Abuse and Mental Health Services Administration (SAMHSA) revealed a rise in alcohol consumption among the 133.1 million current alcohol users aged 12 or older in the United States in 2021. Of these, 25.8 percent reported binge drinking in the past month, and 6.3 percent reported heavy alcohol use during the same period. Moreover, 14.4 million individuals aged 12 or older experienced an alcohol use disorder in the past year, constituting 5.3 percent of people in this age group. Consequently, high alcohol consumption is expected to contribute to the growth of the esophageal cancer market.

The approval of new drugs stands out as a significant trend gaining traction in the esophageal cancer market. Major companies within the esophageal cancer market are directing their efforts towards securing approvals for new drugs, a strategy aimed at enhancing their market position and gaining a competitive edge. An illustrative example is Bristol Myers Squibb, a US-based pharmaceutical company, which obtained approval from the U.S. Food and Drug Administration (FDA) in May 2022 for two of its products such as Opdivo (nivolumab) and Opdivo plus Yervoy (ipilimumab). These products, primarily designed for individuals with advanced or metastatic esophageal squamous cell carcinoma (ESCC), received authorization based on favorable outcomes observed in Phase 3 clinical trials, demonstrating improved overall survival rates among treated patients.

A focus on precision medicine is also evident among major companies operating in the esophageal cancer market, as reflected in product launches. Precision medicine represents an innovative approach to medical treatment that tailors interventions based on individual patients' unique genetic, environmental, and lifestyle characteristics. Previse, a US-based biotechnology company, launched Esopredict in March 2023-a precision medicine solution empowering gastroenterologists to tailor approaches effectively for managing the risk of future cancer diagnoses. Esopredict utilizes The Esoscore derived from Barrett's esophagus cells to offer timely and accurate 5-year risk predictions for esophageal cancer. This groundbreaking product addresses an essential medical need by aiding healthcare providers in identifying patients at risk of progressing to high-grade dysplasia or esophageal cancer, thereby revolutionizing treatment approaches and significantly impacting the esophageal cancer market.

In January 2023, ProPhase Labs, Inc., a US-based next-generation biotech, genomics, and diagnostics company, acquired the rights to the BE-Smart Esophageal Pre-Cancer Diagnostic Screening Test from Stella Diagnostics, Inc. This strategic move positions ProPhase Labs to facilitate healthcare providers in promptly initiating life-saving early treatment measures, such as ablation procedures to eliminate precancerous cells. Stella Diagnostics, Inc., a US-based molecular diagnostics organization, focuses on enhancing patient management strategies.

Major companies operating in the esophageal cancer market include Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc, AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A, Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline Plc., Takeda Pharmaceutical Company Limited, Eli Lilly and Co Ltd., Boehringer Ingelheim International GmbH, Gilead Sciences Inc., Amgen Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Daiichi Sankyo Company Limited, Servier Pharmaceuticals, Eisai Co. Ltd., Sun Pharmaceutical Industries Limited, Otsuka Pharmaceutical Co. Ltd., Ipsen SA, Dr. Reddy's Laboratories Ltd., Seagen Inc., Exelixis Inc., BeiGene Ltd., Clovis Oncology Inc., Aslan Pharmaceuticals Ltd.

North America was the largest region in the esophageal cancer market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the esophageal cancer market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the esophageal cancer market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The esophageal cancer market consists of revenues earned by entities by providing esophageal cancer treatment services such as esophagectomy, palliative care, and brachytherapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The esophageal cancer market consists of sales of fluorouracil, capecitabine, cisplatin, epirubicin, and docetaxel. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Esophageal Cancer Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on esophageal cancer market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for esophageal cancer ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The esophageal cancer market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Esophageal Squamous-Cell Carcinoma; Esophageal Adenocarcinoma; Other Types
• 2) By Treatment Type: Chemotherapy; Targeted Therapy; Other Treatment Types
• 3) By Route Of Administration: Oral; Parenteral; Other Routes Of Administration
• 4) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy
• 5) By End Users: Hospitals; Homecare; Specialty Centers; Other End Users
• Subsegments:
• 1) By Esophageal Squamous-Cell Carcinoma: Localized Squamous-Cell Carcinoma; Advanced Squamous-Cell Carcinoma
• 2) By Esophageal Adenocarcinoma: Localized Adenocarcinoma; Advanced Adenocarcinoma
• 3) By Other Types: Neuroendocrine Tumors; Sarcomas; Mixed Cell Type Carcinomas
• Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche Ltd.; Merck & Co. Inc; AbbVie Inc.; Bayer AG; Novartis AG; Sanofi S.A; Bristol-Myers Squibb Company; AstraZeneca PLC; GlaxoSmithKline Plc.; Takeda Pharmaceutical Company Limited; Eli Lilly and Co Ltd.; Boehringer Ingelheim International GmbH; Gilead Sciences Inc.; Amgen Inc.; Teva Pharmaceutical Industries Ltd.; Astellas Pharma Inc.; Daiichi Sankyo Company Limited; Servier Pharmaceuticals; Eisai Co. Ltd.; Sun Pharmaceutical Industries Limited; Otsuka Pharmaceutical Co. Ltd.; Ipsen SA; Dr. Reddy's Laboratories Ltd.; Seagen Inc.; Exelixis Inc.; BeiGene Ltd.; Clovis Oncology Inc.; Aslan Pharmaceuticals Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Esophageal Cancer Market Characteristics

3. Esophageal Cancer Market Trends And Strategies

4. Esophageal Cancer Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Esophageal Cancer Growth Analysis And Strategic Analysis Framework

• 5.1. Global Esophageal Cancer PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Esophageal Cancer Market Growth Rate Analysis
• 5.4. Global Esophageal Cancer Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Esophageal Cancer Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Esophageal Cancer Total Addressable Market (TAM)

6. Esophageal Cancer Market Segmentation

• 6.1. Global Esophageal Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Esophageal Squamous-Cell Carcinoma
• Esophageal Adenocarcinoma
• Other Types
• 6.2. Global Esophageal Cancer Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chemotherapy
• Targeted Therapy
• Other Treatment Types
• 6.3. Global Esophageal Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Parenteral
• Other Routes Of Administration
• 6.4. Global Esophageal Cancer Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy
• 6.5. Global Esophageal Cancer Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Homecare
• Specialty Centers
• Other End Users
• 6.6. Global Esophageal Cancer Market, Sub-Segmentation Of Esophageal Squamous-Cell Carcinoma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Localized Squamous-Cell Carcinoma
• Advanced Squamous-Cell Carcinoma
• 6.7. Global Esophageal Cancer Market, Sub-Segmentation Of Esophageal Adenocarcinoma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Localized Adenocarcinoma
• Advanced Adenocarcinoma
• 6.8. Global Esophageal Cancer Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Neuroendocrine Tumors
• Sarcomas
• Mixed Cell Type Carcinomas

7. Esophageal Cancer Market Regional And Country Analysis

• 7.1. Global Esophageal Cancer Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Esophageal Cancer Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Esophageal Cancer Market

• 8.1. Asia-Pacific Esophageal Cancer Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Esophageal Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Esophageal Cancer Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Esophageal Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Esophageal Cancer Market

• 9.1. China Esophageal Cancer Market Overview
• 9.2. China Esophageal Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Esophageal Cancer Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Esophageal Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Esophageal Cancer Market

• 10.1. India Esophageal Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Esophageal Cancer Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Esophageal Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Esophageal Cancer Market

• 11.1. Japan Esophageal Cancer Market Overview
• 11.2. Japan Esophageal Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Esophageal Cancer Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Esophageal Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Esophageal Cancer Market

• 12.1. Australia Esophageal Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Esophageal Cancer Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Esophageal Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Esophageal Cancer Market

• 13.1. Indonesia Esophageal Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Esophageal Cancer Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Esophageal Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Esophageal Cancer Market

• 14.1. South Korea Esophageal Cancer Market Overview
• 14.2. South Korea Esophageal Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Esophageal Cancer Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Esophageal Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Esophageal Cancer Market

• 15.1. Western Europe Esophageal Cancer Market Overview
• 15.2. Western Europe Esophageal Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Esophageal Cancer Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Esophageal Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Esophageal Cancer Market

• 16.1. UK Esophageal Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Esophageal Cancer Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Esophageal Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Esophageal Cancer Market

• 17.1. Germany Esophageal Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Esophageal Cancer Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Esophageal Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Esophageal Cancer Market

• 18.1. France Esophageal Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Esophageal Cancer Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Esophageal Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Esophageal Cancer Market

• 19.1. Italy Esophageal Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Esophageal Cancer Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Esophageal Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Esophageal Cancer Market

• 20.1. Spain Esophageal Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Esophageal Cancer Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Esophageal Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Esophageal Cancer Market

• 21.1. Eastern Europe Esophageal Cancer Market Overview
• 21.2. Eastern Europe Esophageal Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Esophageal Cancer Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Esophageal Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Esophageal Cancer Market

• 22.1. Russia Esophageal Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Esophageal Cancer Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Esophageal Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Esophageal Cancer Market

• 23.1. North America Esophageal Cancer Market Overview
• 23.2. North America Esophageal Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Esophageal Cancer Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Esophageal Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Esophageal Cancer Market

• 24.1. USA Esophageal Cancer Market Overview
• 24.2. USA Esophageal Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Esophageal Cancer Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Esophageal Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Esophageal Cancer Market

• 25.1. Canada Esophageal Cancer Market Overview
• 25.2. Canada Esophageal Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Esophageal Cancer Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Esophageal Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Esophageal Cancer Market

• 26.1. South America Esophageal Cancer Market Overview
• 26.2. South America Esophageal Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Esophageal Cancer Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Esophageal Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Esophageal Cancer Market

• 27.1. Brazil Esophageal Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Esophageal Cancer Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Esophageal Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Esophageal Cancer Market

• 28.1. Middle East Esophageal Cancer Market Overview
• 28.2. Middle East Esophageal Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Esophageal Cancer Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Esophageal Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Esophageal Cancer Market

• 29.1. Africa Esophageal Cancer Market Overview
• 29.2. Africa Esophageal Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Esophageal Cancer Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Esophageal Cancer Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Esophageal Cancer Market Competitive Landscape And Company Profiles

• 30.1. Esophageal Cancer Market Competitive Landscape
• 30.2. Esophageal Cancer Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

31. Esophageal Cancer Market Other Major And Innovative Companies

• 31.1. Novartis AG
• 31.2. Sanofi S.A.
• 31.3. Bristol-Myers Squibb Company
• 31.4. AstraZeneca PLC
• 31.5. GlaxoSmithKline Plc.
• 31.6. Takeda Pharmaceutical Company Limited
• 31.7. Eli Lilly and Co Ltd.
• 31.8. Boehringer Ingelheim International GmbH
• 31.9. Gilead Sciences Inc.
• 31.10. Amgen Inc.
• 31.11. Teva Pharmaceutical Industries Ltd.
• 31.12. Astellas Pharma Inc.
• 31.13. Daiichi Sankyo Company Limited
• 31.14. Servier Pharmaceuticals
• 31.15. Eisai Co. Ltd.

32. Global Esophageal Cancer Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Esophageal Cancer Market

34. Recent Developments In The Esophageal Cancer Market

35. Esophageal Cancer Market High Potential Countries, Segments and Strategies

• 35.1 Esophageal Cancer Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Esophageal Cancer Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Esophageal Cancer Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer